FREE web-based Educational Program (www.traineecouncil.org)

The journal Clinical Chemistry recently launched this new worldwide initiative and offers

• a variety of educational materials including Clinical Case Studies,
• Q&A (a virtual roundtable discussion among a group of experts about a hot topic),
• the Guide to Scientific Writing (a series of 14 articles)’
• Webcasts (lectures by leading international scientists),
• Pearls of Laboratory Medicine (15 minute presentations about a laboratory test), and
• CouncilChat (a chat room directed by 6 junior faculty members from around the world).
• more than 120 popular podcasts, which have been downloaded over 450,000 times in the last 2.5 years.

In addition, the journal periodically publishes interviews with world scientific leaders and articles about prominent clinical chemists (Inspiring Minds) that can serve as an inspiration to young scientists. The focus of the Council is broadening to include lectures and educational materials in all disciplines of laboratory medicine including microbiology, transfusion medicine, molecular diagnostics and hematology.

In addition, later this autumn, the Council will launch a questions bank in laboratory medicine for those preparing for board certification or specialist exams in the US and the UK and elsewhere.

This program is currently available in its entirety in English and Spanish and will be launched in Chinese and Russian this year and in Arabic, Japanese and Portuguese next year with the hope of becoming a primary educational resource for laboratory medicine trainees worldwide.

To register in the Council and gain access to all the materials free of charge go to www.traineecouncil.org

Raising awareness of EU ‐ US Biological and Medical Sciences Cooperation

Brussels, May 15, 2012 – On the initiative of Seán Kelly, Member of the European Parliament, a series of
biomedical sciences cooperation seminars will be held in Washington DC. These meetings aim to
encourage further dialogue on international Science Interaction between members of the US Congress,
officials from EU Institutions, and leading international scientists as well as their industry partners. A staff
briefing in the US Congress on US ‐EU IT and Medical Sciences Research Infrastructures will round off the
sequence of seminars and presentations. European Research Infrastructures and scientific initiatives will
be presented on the 4 th – 6 th of June 2012.

Read more:

Raising awareness of EU-US Biological and Medical Sciences Cooperation.pdf

EDMA On the Move Against Tuberculosis
EDMA welcomes Parliament vote on new Commission
ECDC: First European reference laboratory network for tuberculosis launched

EDMA On the Move Against Tuberculosis

24 March 2010

On World Tuberculosis Day 2010, EDMA, the European Diagnostic Manufacturers Association, highlights the importance of innovative In Vitro Diagnostic (IVD) products for the success of global tuberculosis care and control efforts.

EDMA strongly supports this year’s World Tuberculosis Day campaign “Innovate to accelerate action: On the move against tuberculosis”. Tuberculosis (TB) is a worldwide health threat and a serious concern also for the European Union (EU). Although incidence is highest in developing countries, the importation of the disease from countries of the former Soviet Union and the emergence of drug-resistant MDR-TB strains are posing new challenges to European health systems. Out of the 14 countries most affected by MDR-TB, 12 are in the WHO European Region.¹ In total, 12,000 deaths and almost 90,000 new TB-infections were reported in the EU in 2006.²

TB is the world’s second most common cause of death from an infectious agent after HIV, each disease speeding the other’s progress:³ A person with both HIV and TB is 5-6 times more likely to develop active TB than an HIV-negative person.⁴ Therefore, EDMA emphasises the need for systematic access to testing and early diagnosis as crucial factors to halting this dual epidemic.

This year, World Tuberculosis Day focuses on the need for innovative ways of fighting TB. The diagnostic tools used to detect the disease have barely evolved throughout the past century, and EDMA believes that the further development of easy-to-use tests for resource-poor settings is imperative. Therefore, EDMA calls upon the EU to increase funding for R&D of diagnostics which currently account for only 10% of global investments in TB research.⁵

For further reading, please visit Lab Tests Online.

¹ http://www.euro.who.int/tuberculosis/20090108_

² http://www.euro.who.int/tuberculosis/20090108_1

³ http://www.who.int/mediacentre/factsheets/fs104/en/

⁴ http://www.britannica.com/bps/additionalcontent/18/33236616/HIVTuberculosis-CoInfection

⁵ http://www.treatmentactiongroup.org/uploadedFiles/About/Publications/TAG_Publications/2010/2009%20TB%20WEB%20version%203.16.FINAL.pdf#page=12

EDMA welcomes Parliament vote on new Commission

09 February 2010

EDMA, the European Diagnostic Manufacturers Association, welcomes this afternoon’s vote by the European Parliament on the new European Commission. The vote, which took place in Strasbourg, saw MEPs elect a Commissioner from each of the EU Member States with 488 votes in favour, 137 against and 72 abstentions. The work of the new Commission, under President José Manuel Barroso, will begin 10 February.

The “Barroso II” Commission holds a number of important changes for EDMA. The new Commissioner for Health and Consumers, John Dalli, is a former Maltese Minister and MP, with a background in health and social affairs. He impressed MEPs in his January hearing before the European Parliament’s Committee on Environment, Public Health and Food Safety, and showed confidence and familiarity with the topics he will face throughout his mandate. In his hearing, he made clear that his work would focus on the idea that “prevention is better than cure”.In previous Commissions, the work of the In Vitro Diagnostic industry came under the remit of the European Commissioner for Enterprise and Industry. With the restructuring of the Commission, EDMA will be affected by the move of the Cosmetics and Medical Devices Unit from DG Enterprise and Industry to DG Health and Consumers, and thus under the portfolio of Commissioner Dalli. Christine Tarrajat, EDMA Director General, commented that EDMA looks forward to a fruitful cooperation with the Commission over the next five years, especially in light of the recent outcome of the “Exploratory Process on the Future of the Medical Devices Sector”.

ECDC: First European reference laboratory network for tuberculosis launched

25 January 2010

The European Centre of Disease Prevention and Control (ECDC) was established in 2005. It is an EU agency with aim to strengthen Europe’s defences against infectious diseases. It is seated in Stockholm, Sweden., ECDC’s mission is to identify, assess and communicate current and emerging threats to human health posed by infectious diseases. In order to achieve this mission, ECDC works in partnership with national health protection bodies across Europe to strengthen and develop continent-wide disease surveillance and early warning systems. By working with experts throughout Europe, ECDC pools Europe’s health knowledge, so as to develop authoritative scientific opinions about the risks posed by current and emerging infectious diseases ECDC hosted the launch of the European Reference Laboratory Network for Tuberculosis (ERLN-TB) on 25 January 2010 at its first annual meeting in Stockholm, Sweden. Reference laboratories representatives from EU/EEA Member States and candidate countries will engage in an unprecedented initiative in the field of tuberculosis control in the EU. Recognizing laboratory function as one of the pillars of optimal tuberculosis control, the network will aim at strengthening the diagnosis of the disease at EU level, in line with the objectives of the Framework action plan to fight tuberculosis in the European Union. Under ECDC coordination, the ERLN-TB will pursue concerted action in capacity building, quality assurance, scientific advice and support.

The added value of a European Union tuberculosis reference laboratory network (Eurosurveillance, Volume 13, Issue 12, 18 March 2008)

The French Society SFBC (FR)
Association for Clinical Biochemistry (ACB) (UK)
Association of Clinical Biochemists in Ireland (ACBI) (IE)
The Netherlands Society for Clinical Chemistry and Laboratory Medicine (NL)
Swedish Society for Clinical Chemistry (SFKK) (SE)
Swiss Society of Clinical Chemistry (SSCC) (CH)

The French Society SFBC (FR)

Lab Tests Online now available in French

Pr Jean Pierre Bali, general secretary SFBC

Dr Véronique Ducros, co-chair scientific division SFBC

EDMA, the European Diagnostic Manufacturers Association is proud to announce that Lab Tests Online, the non-commercial multilingual information portal on laboratory testing, is now available in French.The launch of the French website took place on Friday 6 November, at the 54th JIB-International Biology Days in Paris. Initially developed by the American Association for Clinical Chemistry (AACC) in the US, Lab Tests Online is a global project with websites in U.K. and Australia as well. EDMA coordinates the project of localising Lab Tests Online in continental Europe. The peer-reviewed, patient-centred, and non-commercial website is already available in Italian, Czech, German, Spanish, Greek, Hungarian, and Polish.

The General Secretary of French Society of Clinical Biology and Laboratory Medicine (SFBC), Jean-Pierre Bali, on behalf Alain Legrand, SFBC President, thanked all of those who attended the event, in particular his counterparts from the US and other European countries who had effectively implemented the website in the past, as well as his colleagues (Mariam Klouche (DE), Stephen Halloran (UK), Alexander Halliassos (GR), Véronique Ducros, Damien Gruson and Bernard Gouget (FR)) on the French Lab Tests Online Committee.

He also welcomed representatives of the French High Health Authority and the State Health Insurance Office, who provided encouragement in the progress and promotion of the website.Lab Tests Online meets both a public need, and the highest quality standards on health information. Both values also appreciated by the European Commission, which has approved the inclusion of the European Lab Tests Online websites on the EU-Health Portal.

Lab Tests Online offers clear and easy to understand information to citizens and physicians about the diverse and advantageous contributions of laboratory medicine to health protection and care. Therefore users can inform themselves about the tests they have been prescribed, the conditions usually related to the assays and how the success of the treatment is evaluated.

To get a better understanding of the project, please visit the website, where you can access all the national sites.

Association for Clinical Biochemistry (ACB) (UK)

Old Eye Hospital Send Off For Janet

Janet Smith and colleagues at the old Eye Hospital in to wish her well after retirement from university hospitals Birmingham

The ACB officers have recently the meeting of Janet Smith’s colleagues, past and present, in the old Eye Hospital in Birmingham. Indeed, this photo is believed to have been taken on the exact spot where the old laboratory was until it moved to Dudley Road in the 1980s.

Janet recently retired from University Hospitals Birmingham. During her career Janet worked tirelessly for the ACB, including being Chair of the Association, plus her huge efforts to take the Education Committee forward. Janet had a number of research interests and was particularly interested in improving the use of HbA1c in diabetic monitoring.

Association of Clinical Biochemists in Ireland (ACBI) (IE)

Report on IEQAS (Irish External Quality Assessment Scheme)

The Annual Conference of the Irish External Quality Assessment Scheme (IEQAS) was held on Thursday October 1st in the Louis Fitzgerald Hotel, Dublin. Approximately 130 delegates attended the meeting, for which we have received very positive feedback regarding both content and facilities.The IQEAS Chairman, Dr Ned Barrett welcomed the delegates before handing over to Mr Mari McDonald.

Head of Workforce Planning and professional education, HSE who gave the opening address entitled “The Modernisation of Laboratory Medicine Services in Ireland: safeguarding quality during times of service reconfiguration”. Ms Patricia Howley, Operations Manager of IEQAS, then presented a review of the scheme’s performance over the last 12 months.

The theme for the remaining plenary sessions was Point of Care testing (POCT) from a number of aspects: comparison of EQA between primary and secondary care (Ms Annette Thomas, WEQAS); new guidelines for primary care to published shortly (Dr Judith Martin, IMB); a pilot study on pharmacy-based lipid screening (Ms Aisling Reast, Irish Pharmacy Union); and finally a survey on hospital-based POCT (Ms Ruth O’Kelly).

The first presentation in the Clinical Chemistry workshop was from Dr Ned Barrett regarding preparations for implementing dual reporting (IFCC/DCCT) of HbAlc in Ireland on 1st July 2010. Dr Mark Lynch from Altnagelvin Tyrone Country and Erne Hospital then spoke about the Northern Ireland Regional Audit Group in Clinical Chemistry.

Ms Hazel Graham, IEQAS Quality Manager, reported the findings of two fresh serum surveys which were carried out by IEQAS.Meanwhile at the parallel Hematology workshop, Dr Kanthi Perera, Midland regional Hospital Tullamore, reviewed the Blood Cell Morphology slides distributed by IEQAS this year. Mr Gerry Judge from AMNCH presented a review of this year’s Labquality Blood Transfusion schemes.Both workshops ended with peer-presented case studies: this aspect was new for the IEQAS programme and was very well received.

In Memoriam: Miss CP (Connie) Glennon, BSc, MSc, MICI

Connie Glennon was born in Ballinasloe Co Galway. She attended university during the War years – a high thinking, low living student in Dominican Hall, St Stephen’s Green just around the corner from lectures in Earlsfort Terrace. She qualified BSc (Hons) 1945 in Chemistry with Maths.
Connie moved straight into an MSc under Professor E J Conway (of Diffusion apparatus fame) on the Permeability of Cell Membranes to Electrolytes. That experience shaped her professionally, in the power of Mathematics and scrupulous analytical technique.
She stayed on in the department for two and half years working for the Medical Research Council.In July 1949 she took the post of Biochemist at the Mater Misericordiae Hospital, Dublin, under Prof Maurice Hickey, State Pathologist. There was no automated equipment. She worked with Mary Leydon when Dr Belle Farrell worked in a separate lab for the Professor of Medicine, Tim Counihan. In 1956, she moved to Belfast to the Mater Infirmorum Hospital and took charge of biochemistry there. She dropped her family pet name (Stanza… from Constantia) and became Connie.

She joined the fledgling (UK) Association of Clinical Biochemists in 1957 and attended summer courses in Clinical Chemistry at Glasgow University and in Birmingham. Connie was a keen and strong golfer. Several times a week she took the bus from work up to Fort William Golf Club to play 18 holes or as long as light allowed. Four years after joining, the club made her Handicap Secretary. When she died their flag flew at half mast.

In 1965 twenty years after her first degree, Connie was promoted to Senior grade. The lab now took in biochemistry, haematology and blood transfusion. Her remit covered day to day lab activity, quality of results and training for all non-medical staff. She insisted that students develop and demonstrate good analytical technique. Jim Mulvenna, John Madden, Brian Cairns and Tim Wyatt saw her with respect first, then later with admiration and affection. She inspired her niece to take up Science. In Belfast in the 1970s and 1980s she made good friends and good conversation without gossip or politics. Margaret Telford, Selby Nesbitt, Mike Smye and Elly Duly remember her example.She retired quietly in 1988. Fourteen years later in 2002, she moved to Sandycove (Dublin) to live with her sister.In her last decades she gave away her golf clubs but joined three separate bridge clubs where she was a respected, winning player. Connie was a lady without fuss. She took delight in a simple card from biochemists North and South sent to honour 50 years’ membership of the ACB; enjoyed music in the National Concert Hall which she had experienced as the Exam Hall of UCD; tried out the Luas tram and took tea in the Shelbourne Hotel.

She died on September 24 2009. She was a pioneer, a dedicated worker during troubled times, and a true lady. RIP.

The Netherlands Society for Clinical Chemistry and Laboratory Medicine (NL)

Noyons’ medal for Dr. Wim Huisman

At the General Meeting of November is the last Noyons Medal 2009 awarded to Dr. Wim Huisman. This medal, named after the founder of the NVKC, Dr EC Noyons, is intended particularly for those who have rendered the association. Huisman receive the medal for his relentless efforts to care and quality awareness high on the national and international agendas, and also get to see translated into concrete actions.

Swedish Society for Clinical Chemistry (SFKK) (SE)

The light! Now, there is typically well that the days getting longer again. All Christmas is long since eaten and pat are already old dear friends. The worst cold clasps for a long time is over, time passes quickly and soon it is spring. Best of all is that so much is going good and fun in Clinical Chemistry in the future.

Travel Grants! Now spends SFKK back on travel scholarships for its members. It is important to come out and talk about their projects. It is important to get out and listen and learn from others. That is how we evolve and develop. Read more in separate ad later in the paper.

ST-training! This happens a lot right now. We have a new national ST studies, and we have a new mission statement according to new principles. Now it’s time to tie up the bag and see what courses we offer and how we do follow-up with knowledge. Sign up for our ST-training session on 4 March in Stockholm. Read more under the “Current sessions”.

Spring meeting! Dates, programs and location ensures that the fjord this year’s success in Kalmar to be repeated. Stockholm is nice at the end of April and the program is filled with substances which Karolinska has a prominent place in development and research. There is only one thing to do – sign up

XXXII Nordic Congress in Medical Biochemistry! Dates, programs and location also ensures a lovely Nordic meeting. Oslo is nice in early June when the days are the longest and it’s rocking outside on the terraces. Add to this an exciting program with both international and Swedish contributions. There is only one thing to do – sign up

IFCC calibration of HbA1c! Jan-Olof Jeppsson and Gunnar Nordin, two champions in the effort to create an international collaboration of HbA1c may soon a fantastic dividend by the imminent introduction of a single global joint calibration of HbA1c. A huge success for Clinical Chemistry. In September we go over. In short you can read the recommendations from SFKK on how to do this. 2010 will be an eventful year for our specialty.

Have a nice winter, once it is spring!

Swiss Society of Clinical Chemistry (SSCC) (CH)

The list of members of the different scientific working groups as well as the description of their goals has been recently updated.

The Mass Spectrometry (MS) working group is organising courses in mass spectrometry to share knowledge on the possibilities and use of the technology in Laboratory Medicine.The goals are to inform about the analyses processed in Switzerland that use Mass Spectrometry as analytical tool; a growing list of laboratories is made available on the website of the SSCC; and to keep contact and exchange experience with similar activities in other countries.

The Transformation of Medical Biology in France: a Benchmark for the EU?

Within the context of the HPST (hospital, patient, health, and territories) called “the Bachelot law” and under the leadership of M. Ballereau and A.M. Gallot, governmental experts, the new law (legislative order) reforming medical biology was published in the official journal of the French Republic on January 15, 2010. Medical biology tests are medical procedures in their own right: this is the central point upon which the reform of French medical biology is focused. This reform places medical biology fully at the heart of hospital professions and patient management, becoming a determining step in healthcare delivery for the diagnosis of most pathologies and treatment follow-up.

This legislation modernizes the legal framework for medical laboratories (laboratories de biologie médicale – LBM) laid down in 1975, to take into account medical and scientific innovations, which have occurred in the discipline since that time. It provides a uniform framework for the practice of the profession, and sets out to improve the quality of service through compulsory ISO 15189 accreditation for all laboratories, no later than the end of 2016.

The Order contains 11 articles and first gives a definition of medical biology testing, the conditions under which it is to be carried out, the duties incumbent on medical laboratories, and the role of medical biologist. It is a medical procedure, which contributes towards the prevention of disease, screening, diagnosis and evaluation of the risks of onset of pathological conditions, as well as part of the decision-making, therapeutic management, and the determination or follow-up of physiological or physiopathological conditions of the human being.

In particular, the Order specifies the conditions for conducting medical biology tests outside the laboratory, and sets limits for the scope of this discipline (point-of-care testing, fast screening tests for use by clinicians and home tests for patients). The involvement of the medical biologist in the therapeutic education of patients is set out, notably for the new inspection of self-monitoring measurement devices.

The reform reasserts the professional transformation of the discipline. No longer a technician, the medical biologist has a full medical role to play and is part of patient management. Together with the clinical practitioner, the medical biologist is now responsible for the entirety of the medical procedure henceforth called a medical biology examination. Medical biologist-clinical practitioner communication is reinforced: obtaining relevant clinical information, the right to “substitute” examinations having regard to rules of good practice for proper prescription. The responsibility of the medical biologist in the preanalysis phase is specified, for example, with respect to sampling procedures in public and private sectors and in different situations (laboratory, home, care institution). The converging points with pathological anatomy and cytology are specified.

The medical biologist is a doctor or pharmacist holding a specialization diploma in Medical Biology. The rules authorizing the practicing of this discipline by other professionals, notably those trained in other countries are laid down. Should the professional qualification, as certified by training certificates issued by third party States and relevant professional experience, indicate any substantial differences compared with required qualifications in France, compensation measures are to be followed in the form of aptitude tests or adaptation courses.

The Reform therefore sets out to harmonize the operating rules for clinical pathology laboratories between the private sector and the public sector. It facilitates cooperation between public institutions and the two sectors, notably through public health cooperation groups. The Order further comprises measures intended to sustain the continuum of medical biology services within one same public health territory. The Reform also sets out to achieve the grouping of laboratories and to maintain territorial limits for medical laboratory activity. Medical laboratories may be multisite (single laboratory in a hospital or hospital district within the territory), but these sites must not be set up on more than three adjoining public health territories, unless dispensation is given by the regional public health authority .

The Reform sets up systems to guarantee a plurality of offer for medical laboratory services within a public health territory by laying down so-called precautionary rules. It is prohibited in particular for a person, whether legal or natural, to acquire shares in companies operating a medical laboratory if the result of this acquisition would be to enable such person to control a proportion, whether directly or indirectly, that is more than “33% of the total quantity of medical laboratory examinations conducted” within one same infraregional public health territory.

The Order also prohibits an interest in the share capital of laboratories to be taken by legal or natural persons engaged in a health profession authorized to prescribed pathology examinations, or engaged in the activity of supplier, distributor or manufacturer of in vitro medical diagnosis devices, or employed by an insurance company, or by provident, pension or social welfare bodies.

The Order encourages the professionalized inspection, i.e., with the imposed order and structure of examinations on the basis of reference systems, published in particular by the national authority for health (Haute Autorité de Santé – HAS) and introduces a financial penalty for any medical laboratories conducting any examinations that are not warranted under the nomenclature of medical biology procedures or under good practice recommendations in force.

The Order sets up a compulsory accreditation scheme for medical laboratories, the deadline of which is November 1, 2016, with an interim date of November 1, 2013, when evidence must be provided that they have taken steps to obtain this accreditation. This accreditation concerns all laboratories, private and public, university and non university, to reinforce the quality and safety of testing. The French accreditation committee (Comité français d’accreditation -COFRAC) is the sole body granting this accreditation based on standards NF EN ISO 15189 and 22870. Decisions given by the COFRAC are to be transmitted to the national authority for health (HAS), to the French health products safety agency (Agence française de sécurité sanitaire des produits de santé -AFSSAPS), to the Biomedicine Agency (ABM) and to the Regional Health Agency (ARS).

The Order also redefines the National Quality Control of medical biology test results, to be ensured by AFSSAPS, and additionally an obligation of external quality evaluation is introduced for all medical biology tests.

The Order also specifies the conditions for inspections to be carried out by inspection officers and their relations with COFRAC. Administrative, disciplinary, and criminal penalties are determined.

The Order describes the conditions under which medical laboratory technicians must practice their profession i.e., medical biology, or cytopathological anatomy. This particular article enables laboratory technicians to enter into the category of health professionals.

France is at the forefront in setting up compulsory accreditation. Taking part in a clinical research trial has become a challenge if a medical laboratory is not accredited. Accreditation contains the word “credit,” i.e., confidence. Etymologically, therefore, the purpose is to reinforce trust. Regulatory restrictions are the evincing of changes in context, and a response to our citizens’ expectations with regard to public health, and indeed the expectations of the international scientific community. Having regard to the critical nature of this undertaking, the IFCC, EFCC, and the ILAC (International Laboratory Accreditation Cooperation) are soon to sign a memorandum of mutual understanding not only to strengthen the credibility and trust in clinical pathology in line with internationally recognized rules, but also to support the community of clinical pathologists in the face of these cultural changes.

2nd EFLM-BD European Conference – Travel Grants
Guide to the European Register of Specialists in Clinical Chemistry and Laboratory Medicine
EFLM Newsletters
EFLM News

2nd EFLM-BD European Conference – Travel Grants

EFLM is pleased to offer two travel grants (1500 EUR each) for young participants of the 2nd EFLM-BD European Conference on Preanalytical Phase – Zagreb, 1-2 March 2013.

Candidates should fulfil the following criteria:

• Young participant (<40 years on March 1^st , 2013)
• Applicant should be a member of the EFLM member society
• Applicant must submit a poster
• Short CV must be provided with a list of publications. Preference shall be given to the candidates with more publications. Quality of papers will be taken into account.

Applications should be sent to EFLM office (eflm@ifcc.org) by not later than January 15^th. Applicants shall be notified about the award winners by January 20^th.

Guide to the European Register of Specialists in Clinical Chemistry and Laboratory Medicine

Version 3 of the Guide to the EC4 European Register (local copy) has been published in Clinical Chemistry and Laboratory Medicine (CCLM 2010;48(7):999-1008;). This updates the previous version published in 2003. The standards of education and professional training and the competencies required for registration are described. The Guide details the operation of the Register, the application procedure, the Register’s relationship to the national societies and national registers, and the governance arrangements. Registration is valid for five years and the procedure and criteria for re-registration are described.

EFLM (EFCC) Newsletters

February 2013

Editorial

• Summary of the Fifth EFLM General Assembly
• News of the EFLM Working Groups
• News from European Union
• Membership news
• EFLM Awards
• New deadline – EFLM-Labs Are Vital Award
• The Nobel Prizes 2012
• News from the IVD Industry
• EFLM Website – new section “Job Announcements”
• EFLM Events
• Clinical Cases

EFLM Newsletter 02-2013.pdf or Click Here!

September 2012

• Point of View: The Eurocrisis – a changed Framework
• EFLM Congresses/Courses
• News from EFLM Members
• News from the EFLM Committees
• News from EFLM Working Groups
• News from International Organizations

EFLM Newsletter September 2012.pdf or Click Here!

June 2012

• News from the EFLM Executive Board
• News from EFLM Full Members
• News from The EFLM Working Parties
• Partnership between International organizations
• 2nd EFCC-UEMS European Joint Congress: Laboratory Medicine at the Clinical Interface
• EFLM presence at National Society meetings
• New President of the Croatian Society of Medical Biochemistry and Laboratory Medicine

EFLM Newsletter 2012-06.pdf or Click Here!

January 2012

• Berlin 2011 – Paris 2015
• The 4th EFCC General Assembly, Berlin, May15 2011 at a glance
• The EFCC/Labs Are Vital Award for Excellence in Outcomes Research in Laboratory Medicine
• News from National Societies

EFLM Newsletter 2012-01.pdf or Click Here!

May 2011

• Executive Board
• Committee and Working Group Activities
• EFCC events in collaboration with partner organizations
• News from National Societies
• EDMA News
• European Project
• EFCC Forthcoming Events

EFLM Newsletter 2011-05.pdf

January 2011

• Committee and Working Group Activities
• EFCC Education and Training Committee
• EFCC events in collaboration with partner organizations
• EFCC partner organizations
• News from EFCC National Societies
• EFCC Awards
• EFCC Forthcoming Events
• EDMA News
• eHealth

EFLM Newsletter 2011-01.pdf

August 2010

• EFCC 3rd General Assembly
• EFCC Committee and Working Group activities
• News from EFCC National Societies
• Lab Tests Online News
• EFCC-Labs are Vital Award
• News from EFCC partner organizations
• EFCC events in collaboration with corporate partners
• EDMA News
• EFCC and European projects
• EFCC, EU Health agencies and Public Health

June 2010

EFLM Newsletter 2010-06.pdf

May 2009

EFLM Newsletter 2009-05.pdf
Report on EFLM Symposia for Balkan Region.pdf

EFLM (EFCC) News

EFCC – Simone Zerah elected as a Vice-President on the CEPLIS Executive Board.pdf